A lawsuit against the manufacturers of Tylenol arguing its alleged link to autism can proceed after a U.S. appeals court reversed the decision of a judge who previously dismissed it over a lack of scientific evidence.
The move has revived more than 500 private lawsuits against Tylenol maker Kenvue and comes less than a year after President Donald Trump urged pregnant women not to take the painkiller over its links to autism — a claim scientists said is based on “no evidence whatsoever.”
